Advisory Alpha’s Vertex Pharmaceuticals VRTX Stock Holding History

Advisory Alpha's VRTX Position: Q2 2026 in Review

Advisory Alpha reduced its Vertex Pharmaceuticals (VRTX) stake by 0.1% in Q2 2026, selling an estimated $886 and leaving 1,999 shares worth $993K. The position accounts for 0.02% of the portfolio, ranked #221.

Advisory Alpha first reported a position in VRTX in Q1 2019 and has held it in 15 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

• Advisory Alpha held 1,999 shares of Vertex Pharmaceuticals worth $993K as of Q2 2026.
• Advisory Alpha sold 2 Vertex Pharmaceuticals shares in Q2 2026, an estimated $886.
• Vertex Pharmaceuticals made up 0.02% of Advisory Alpha's portfolio in Q2 2026, its #221 holding.
• Advisory Alpha first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 15 quarters since.
• 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Advisory Alpha's 13F filing for Q2 2026, filed 11 Aug 2026.